Patients With Psoriatic Arthritis-Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions

CONCLUSION: In this real-world study, TOF showed a reasonably good retention rate in a PsA population that was mostly refractory to biologic and oral targeted synthetic disease-modifying antirheumatic drugs. There were no new causes for concern regarding safety. Patients with refractory PsA and enthesitis might be a specific target population for this drug.PMID:38561189 | DOI:10.3899/jrheum.2024-0016

Source: J Rheumatol - April 1, 2024 Category: Rheumatology Authors: Ignacio Bra ña Marta Loredo Estefan ía Pardo Stefanie Burger Eva Fern ández-Bretón Rub én Queiro Source Type: research